Back to Search
PAUL FREDA, MD
MD
Psychiatry Physician
NPI: 1588626394Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?
PMID 19226264·Clin Endocrinol (Oxf)·2009
6-review
Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry.
PMID 19491226·J Clin Endocrinol Metab·2009
8-other
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.
PMID 18349062·J Clin Endocrinol Metab·2008
4-observational
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
PMID 17594522·Pituitary·2007
8-other
Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.
PMID 15886238·J Clin Endocrinol Metab·2005
4-observational
Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
PMID 14764751·J Clin Endocrinol Metab·2004
8-other
Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors.
PMID 15638294·Pituitary·2004
5-case
Current concepts in the biochemical assessment of the patient with acromegaly.
PMID 12914750·Growth Horm IGF Res·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 211 W MAIN ST
STERLING, CO 80751 - Phone
- (970) 522-4392
Quick Facts
- NPI
- 1588626394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile